Moraga, California
United States
45
2019-08-01
The entities that hold a legal rights for patent applications filed by inventor BENNETT Mark K.:
Mark K. BENNETT from Moraga, US has applied for patents for these inventions. The list has both pending applications and granted patents:
Combination therapy with glutaminase inhibitors and immuno-oncology agents
#2 | 2018-03-01Combination therapy with glutaminase inhibitors
#3 | 2017-04-06Combination therapy with glutaminase inhibitors and immuno-oncology agents
#4 | 2016-10-06METHODS OF ADMINISTERING GLUTAMINASE INHIBITORS
#5 | 2015-01-01TREATMENT OF CANCER WITH HETEROCYCLIC INHIBITORS OF GLUTAMINASE
#6 | 2014-04-10COMPOUNDS FOR ENZYME INHIBITION
#7 | 2014-03-20COMPOUNDS FOR ENZYME INHIBITION
#8 | 2013-12-19Compounds for enzyme inhibition
#9 | 2013-03-21Compounds for immunoproteasome inhibition
#10 | 2013-02-28Compounds for enzyme inhibition
#11 | 2013-02-14Compounds for enzyme inhibition
#12 | 2013-02-07Compounds for enzyme inhibition
#13 | 2012-04-12Compounds for enzyme inhibition
#14 | 2011-09-29COMBINATION THERAPY WITH PEPTIDE EPOXYKETONES
#15 | 2010-08-05Substrate for Rpn 11 enzymatic activity
#16 | 2010-06-10Compounds for enzyme inhibition
#17 | 2010-06-10Compounds for enzyme inhibition
#18 | 2009-08-27COMPOUNDS FOR ENZYME INHIBITION
#19 | 2008-10-23In vivo production of cyclic peptides for inhibiting protein-protein interaction
#20 | 2008-09-16Compounds that modulate processes associated with IgE production
#21 | 2008-05-27Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a thioredoxin-like 32 kDa protein
#22 | 2008-05-20Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a chloride intracellular channel 1 protein
#23 | 2008-05-08Methods of identifying compounds that modulate IL-4 receptor mediated IgE synthesis utilizing a CLLD8 protein
#24 | 2008-01-10Methods of assaying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a thioredoxin-like 32 kDa protein (TXNL)
#25 | 2008-01-03METHODS OF IDENTIFYING COMPOUNDS THAT MODULATE IL-4 RECEPTOR-MEDIATED IGE SYNTHESIS UTILIZING AN ADENOSINE KINASE
#26 | 2008-01-03METHODS OF IDENTIFYING COMPOUNDS THAT MODULATE IL-4 RECEPTOR-MEDIATED IGE SYNTHESIS UTILIZING A B-CELL ASSOCIATED PROTEIN
#27 | 2007-12-27Method for identifying compounds that modulate RXR associated processes with IgE production
#28 | 2007-12-27Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a chloride intracellular channel 1 protein
#29 | 2007-12-20Compounds for enzyme inhibition
#30 | 2007-10-18METHODS OF IDENTIFYING COMPOUNDS THAT MODULATE IL-4 RECEPTOR-MEDIATED IGE SYNTHESIS UTILIZING A C-MYC PROTEIN
#31 | 2007-08-07In vivo production of cyclic peptides for inhibiting protein—protein interaction
#32 | 2007-07-10Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a c-MYC protein
#33 | 2007-06-14Methods of Identifying Compounds that Modulate IL-4 Receptor-Mediated IgE Synthesis Utilizing a B-Cell Associated Protein
#34 | 2007-05-10In vivo production of cyclic peptides
#35 | 2007-03-13Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a B-cell associated protein
#36 | 2007-03-08Methods of Identifying Compounds that Modulate IL-4 Receptor-Mediated IgE Synthesis Utilizing an Adenosine Kinase
#37 | 2006-12-14Substrate for Rpn11 enzymatic activity
#38 | 2006-12-07Inhibitors of Tubulin Polymerization
#39 | 2006-11-28Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing an adenosine kinase
#40 | 2006-08-31Methods for enzyme inhibition
#41 | 2006-07-04Inhibitors to tubulin polymerization
#42 | 2006-04-27Compounds for enzyme inhibition
#43 | 2005-12-27Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a CLLD8 protein
#44 | 2005-11-24In vivo production of cyclic peptides for inhibiting protein-protein interaction
#45 | 2005-05-26Methods of identifying compounds that modulate IL-4 receptor mediated IgE synthesis utilizing a CLLD8 protein
79841 ⎘